Szöőr Árpád

1.

Tóth, A., Lente, G., Csiki, D. M., Balogh, E., Szöőr, Á., Nagy, B. J., Jeney, V.: Activation of PERK/eIF2α/ATF4/CHOP branch of endoplasmic reticulum stress response and cooperation between HIF-1α and ATF4 promotes Daprodustat-induced vascular calcification.
Front. Pharmacol. 15, 1-12, (article identifier: 1399248), 2024.

doi DEA WoS Scopus

Journal metrics:

Q1 Pharmacology (2023)

Q1 Pharmacology (medical) (2023)

2.

Ababneh, H. M., Tóth, A., Lente, G., Balogh, E., Csiki, D. M., Nagy, B. J., Szöőr, Á., Jeney, V.: High phosphate and calcium induce osteoblastic phenotype switching and calcification of corneal epithelial cells in a Runx2-dependent and synergistic manner; a possible mechanism of chronic kidney disease-associated corneal calcification.
Biochim. Biophys. Acta. Mol. Basis Dis. 1870 (5), 1-20, (article identifier: 167171), 2024.

doi DEA Scopus

Journal metrics:

Q1 Molecular Biology (2023)

Q1 Molecular Medicine (2023)

3.

Lupsa, N., Érsek, B., Böröczky, C., Kis, D., Szarka, E., Lumniczky, K., Sáfrány, G., Zádori, Z. S., Szöőr, Á., Buzás, E., Pos, Z.: High sensitivity of host Helios+/Neuropilin-1+ Treg to pretransplant conditioning hampers development of OX40 bright/integrin-β7+ regulatory cells in acute gastrointestinal GvHD.
Eur. J. Immunol. [Epub ahea dof print], 2024.

doi DEA WoS Scopus

Journal metrics:

Q1 Immunology (2023)

Q1 Immunology and Allergy (2023)

4.

Medyouni, G., Vörös, O., Jusztus, V., Panyi, G., Vereb, G., Szöőr, Á., Hajdu, P.: Inhibition of K+ Channels Affects the Target Cell Killing Potential of CAR T Cells.
Cancers (Basel). 16 (22), 1-12, (article identifier: 3750), 2024.

doi DEA

Journal metrics:

Q2 Cancer Research (2023)

Q1 Oncology (2023)

5.

Barden, M., Elsenbroich, P. R., Haas, V., Ertelt, M., Pervan, P., Velas, L., Gergely, B., Szöőr, Á., Harrer, D. C., Bezler, V., Holzinger, A., Friis, R. U. W., Vereb, G., Schütz, G., Schoeder, C. T., Hombach, A. A., Abken, H.: Integrating binding affinity and tonic signaling enables a rational CAR design for augmented T cell function.
J. Immunother. Cancer. 12 (12), 1-14, (article identifier: 010208), 2024.

doi DEA WoS Scopus

Journal metrics:

D1 Cancer Research (2023)

D1 Molecular Medicine (2023)

D1 Oncology (2023)

D1 Immunology and Allergy (2023)

D1 Immunology (2023)

D1 Pharmacology (2023)

6.

Nagy, L., Mezősi-Csaplár, M., Rebenku, I., Vereb, G., Szöőr, Á.: Universal CAR T cells targeted to HER2 with a biotin-trastuzumab soluble linker penetrate spheroids and large tumor xenografts that are inherently resistant to trastuzumab mediated ADCC.
Front. Immunol. 15, 1-38, (article identifier: 1365172), 2024.

doi DEA WoS Scopus

Journal metrics:

Q1 Immunology (2023)

Q1 Immunology and Allergy (2023)

7.

Barden, M., Holzinger, A., Velas, L., Mezősi-Csaplár, M., Szöőr, Á., Vereb, G., Schütz, G., Hombach, A. A., Abken, H.: CAR and TCR form individual signaling synapses and do not cross-activate, however, can co-operate in T cell activation.
Front. Immunol. 14, 1-13, (article identifier: 1110482), 2023.

doi DEA WoS Scopus

Journal metrics:

Q1 Immunology

Q1 Immunology and Allergy

8.

Mezősi-Csaplár, M., Szöőr, Á., Vereb, G.: CD28 and 41BB Costimulatory Domains Alone or in Combination Differentially Influence Cell Surface Dynamics and Organization of Chimeric Antigen Receptors and Early Activation of CAR T Cells.
Cancers (Basel). 15 (12), 3081-3097, (article identifier: 3081), 2023.

doi DEA WoS Scopus

Journal metrics:

Q2 Cancer Research

Q1 Oncology

9.

Csiki, D. M., Ababneh, H. M., Tóth, A., Lente, G., Szöőr, Á., Tóth, A., Fillér, C., Juhász, T., Nagy, B. J., Balogh, E., Jeney, V.: Hypoxia-inducible factor activation promotes osteogenic transition of valve interstitial cells and accelerates aortic valve calcification in a mice model of chronic kidney disease.
Front. Cardiovasc. Med. 10, 1-15, (article identifier: 1168339), 2023.

doi DEA Scopus

Journal metrics:

Q2 Cardiology and Cardiovascular Medicine

10.

Tóth, A., Csiki, D. M., Nagy, B. J., Balogh, E., Lente, G., Ababneh, H. M., Szöőr, Á., Jeney, V.: Daprodustat Accelerates High Phosphate-Induced Calcification Through the Activation of HIF-1 Signaling.
Front. Pharmacol. 13, 1-12, (article identifier: 798053), 2022.

doi DEA WoS Scopus

Journal metrics:

Q1 Pharmacology

Q1 Pharmacology (medical)

11.

Cserepes, M., Nelhűbel, G. A., Meilinger-Dobra, M., Herczeg, A., Türk, D., Hegedűs, Z., Svajda, L., Rásó, E., Ladányi, A., Csikó, K. G., Kenessey, I., Szöőr, Á., Vereb, G., Remenár, É., Tóvári, J.: EGFR R521K Polymorphism Is Not a Major Determinant of Clinical Cetuximab Resistance in Head and Neck Cancer.
Cancers (Basel). 14 (10), 1-15, (article identifier: 2407), 2022.

doi DEA WoS Scopus

Journal metrics:

Q2 Cancer Research

Q1 Oncology

12.

Bencze, D., Fekete, T., Pfliegler, V. P., Szöőr, Á., Csoma, E., Szántó, A., Tarr, T., Bácsi, A., Kemény, L. V., Veréb, Z., Pázmándi, K. L.: Interactions between the NLRP3-Dependent IL-1β and the Type I Interferon Pathways in Human Plasmacytoid Dendritic Cells.
Int. J. Mol. Sci. 23 (20), 1-34, 2022.

doi DEA WoS Scopus

Journal metrics:

Q2 Catalysis

Q1 Computer Science Applications

D1 Inorganic Chemistry

Q1 Medicine (miscellaneous)

Q2 Molecular Biology

Q1 Organic Chemistry

Q1 Physical and Theoretical Chemistry

D1 Spectroscopy

13.

Blokon-Kogan, D., Levi-Mann, M., Malka-Levy, L., Itzhaki, O., Besser, M. J., Shiftan, Y., Szöőr, Á., Vereb, G., Gross, G., Abken, H., Weinstein-Marom, H.: Membrane anchored IL-18 linked to constitutively active TLR4 and CD40 improves human T cell antitumor capacities for adoptive cell therapy.
J Immunother Cancer. 10 (9), 1-12, (article identifier: 001544), 2022.

doi DEA WoS Scopus

Journal metrics:

D1 Cancer Research

D1 Pharmacology

D1 Immunology

D1 Immunology and Allergy

D1 Molecular Medicine

D1 Oncology

14.

Guti, E., Regdon, Z., Sturniolo, I., Kiss, A., Kovács, K., Demény, M. Á., Szöőr, Á., Vereb, G., Szöllősi, J., Hegedűs, C., Polgár, Z., Virág, L.: The multitargeted receptor tyrosine kinase inhibitor sunitinib induces resistance of HER2 positive breast cancer cells to trastuzumab-mediated ADCC.
Cancer Immunol. Immunother. 71 (9), 2151-2168, 2022.

doi DEA WoS Scopus

Journal metrics:

Q1 Cancer Research

Q1 Immunology

Q1 Immunology and Allergy

D1 Medicine (miscellaneous)

Q1 Oncology

15.

Mezősi-Csaplár, M., Szöllősi, J., Gottschalk, S., Vereb, G., Szöőr, Á.: Cytolytic Activity of CAR T Cells and Maintenance of Their CD4+ Subset Is Critical for Optimal Antitumor Activity in Preclinical Solid Tumor Models.
Cancers (Basel). 13 (17), 1-19, 2021.

doi DEA WoS Scopus

Journal metrics:

Q2 Cancer Research

Q1 Oncology

16.

Varga, Z., Rácz, E., Türk-Mázló, A., Korodi, M., Szabó, A., Molnár, T., Szöőr, Á., Veréb, Z., Bácsi, A., Koncz, G.: Cytotoxic activity of human dendritic cells induces RIPK1-dependent cell death.
Immunobiology. 226 (1), 1-7, 2021.

doi DEA WoS Scopus

Journal metrics:

Q2 Hematology

Q3 Immunology

Q3 Immunology and Allergy

17.

Szöőr, Á., Szöllősi, J., Vereb, G.: From antibodies to living drugs: quo vadis cancer immunotherapy?.
Biol. Futura. 72 (1), 85-99, 2021.

doi DEA

Journal metrics:

Q2 Agricultural and Biological Sciences (miscellaneous)

Q3 Biochemistry, Genetics and Molecular Biology (miscellaneous)

18.

Tóth, G., Szöllősi, J., Abken, H., Vereb, G., Szöőr, Á.: A Small Number of HER2 Redirected CAR T Cells Significantly Improves Immune Response of Adoptively Transferred Mouse Lymphocytes against Human Breast Cancer Xenografts.
Int. J. Mol. Sci. 21 (3), 1-11, 2020.

doi DEA WoS Scopus

Journal metrics:

Q2 Catalysis

D1 Computer Science Applications

D1 Inorganic Chemistry

Q1 Medicine (miscellaneous)

Q2 Molecular Biology

D1 Organic Chemistry

D1 Physical and Theoretical Chemistry

D1 Spectroscopy

19.

Volpin, V., Michels, T., Sorrentino, A., Menevse, A. N., Knoll, G., Ditz, M., Milenkovic, V. M., Chen, C. Y., Rathinasamy, A., Griewank, K., Boutros, M., Haferkamp, S., Berneburg, M., Wetzel, C. H., Seckinger, A., Hose, D., Goldschmidt, H., Ehrenschwender, M., Witzens-Harig, M., Szöőr, Á., Vereb, G., Khandelwal, N., Beckhove, P.: CAMK1D Triggers Immune Resistance of Human Tumor Cells Refractory to Anti-PD-L1 Treatment.
Cancer Immunol. Res. 8, 1163-1179, 2020.

doi DEA WoS Scopus

Journal metrics:

D1 Cancer Research

D1 Immunology

20.

Szöőr, Á., Tóth, G., Zsebik, B., Szabó, V., Eshhar, Z., Abken, H., Vereb, G.: Trastuzumab Derived HER2-specific CARs for the Treatment of Trastuzumab-Resistant Breast Cancer: CAR T Cells Penetrate and Eradicate Tumors That Are Not Accessible to Antibodies.
Cancer Lett. 484, 1-8, 2020.

doi DEA

Journal metrics:

Q1 Cancer Research

Q1 Oncology

21.

Méhes, E., Baráth, M., Gulyás, M., Bugyik, E., Geiszt, M., Szöőr, Á., Lányi, Á., Czirok, A.: Enhanced endothelial motility and multicellular sprouting is mediated by the scaffold protein TKS4.
Sci. Rep. 9 (1), 1-13, 2019.

doi DEA WoS Scopus

Journal metrics:

D1 Multidisciplinary

22.

Bosire, R., Nánási, P. P. i., Imre, L., Dienes, B., Szöőr, Á., Türk-Mázló, A., Kovács, A., Seidel, R., Vámosi, G., Szabó, G.: Intercalation of small molecules into DNA in chromatin is primarily controlled by superhelical constraint.
PLoS One. 14 (11), e0224936, 2019.

doi DEA WoS Scopus

Journal metrics:

D1 Multidisciplinary

23.

Velasquez, M. P., Szöőr, Á., Vaidya, A., Thakkar, A., Nguyen, T. L. P., Wu, M. F., Liu, H., Gottschalk, S.: CD28 and 41BB Costimulation Enhances the Effector Function of CD19-Specific Engager T Cells.
Cancer Immunol. Res. 5 (10), 860-870, 2017.

doi DEA

Journal metrics:

D1 Cancer Research

D1 Immunology

24.

Szöőr, Á., Vereb, G.: Kiméra antigénreceptorral módosított T-sejtek: új fegyverek a daganatterápiában.
Immunol. Szle. 9 (2), 4-11, 2017.

DEA

25.

Szöőr, Á., Vaidya, A., Velasquez, M. P., Mei, Z., Galvan, D. L., Torres, D., Gee, A., Heczey, A., Gottschalk, S.: T Cell-Activating Mesenchymal Stem Cells as a Biotherapeutic for HCC.
Mol. Ther Oncolytics. 28 (6), 69-79, 2017.

doi DEA

Journal metrics:

Q2 Cancer Research

Q2 Molecular Medicine

Q2 Oncology

Q1 Pharmacology (medical)

Publication list